The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Drug combination slows progression of treatment resistant bone marrow cancer

CHAPEL HILL -- Combining a newly formulated drug with one that is already a standard treatment slows the progression of multiple myeloma, an advanced cancer of the bone marrow cells, according to a clinical trial led by a University of North Carolina at Chapel Hill School of Medicine researcher.

The phase III trial included 646 patients from 18 countries with relapsed or refractory multiple myeloma, a condition in which cancerous cells continue to multiply despite treatment. Patients in the trial were randomly assigned to receive the drug bortezomib (Velcade), standard therapy for relapsed multiple myeloma, or a combination of Velcade and Doxil, a chemotherapy drug (doxorubicin) delivered via liposomes, or microscopic fat bubbles.

An interim analysis of study participants who received the combination treatment showed a better response in the combination group than in participants who received standard treatment. The combination group's median time to progression - the time interval between the response to treatment and the time the disease starts to show evidence of growing or recurring - was 9.3 months, while those on Velcade alone progressed after 6.5 months.

The three-month improvement is an important step forward in treatment for multiple myeloma, said Dr. Robert Orlowski, Lenvel Lee Rothrock associate professor in the department of hematology/oncology at the School of Medicine, and a member of the UNC Lineberger Comprehensive Cancer Center.

Orlowski presented the trial's early results on Monday (Dec. 11), at the meeting of the American Society of Hematology in Orlando, Fla. The study was supported by Johnson & Johnson, which owns Ortho Biotech, the maker of Doxil, and also has a financial interest in Velcade.

"The data for time to progression were so positive and encouraging that we decided to announce this information earlier than anticipated so more people could be aware of the benefits of this combination,
'"/>

Contact: L. H. Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine
12-Dec-2006


Page: 1 2

Related medicine news :

1. Phase II study shows combination improves survival of metastatic melanoma patients
2. Certain combination therapy found more effective for treating malaria in African children
3. To get blood pressure under control, combination of medicines may be best
4. Drug/intervention combinations offer benefit in severe CVD
5. Scripps research combination therapy obliterates new vessel growth in tumors and retinopathy
6. Drug combination proves effective against myeloma in Phase I trial
7. Drug combination could reduce risk of severe asthma attacks
8. Transplant patients keep their new kidney longer with a CellCept-based drug combination
9. Rheumatoid arthritis patients can benefit from Enbrel in combination with methotrexate
10. New combination therapy after surgery improves survival for pancreatic cancer patients
11. International study launched testing new drug combination to cut cardiovascular disease

Post Your Comments:
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq...ilitysolutionsforthehealthcareandcommercialindustr...ManagedServicesatSiemensHealthServices,hasjoinedIn...s. ,, (Logo: http://www.newscom.com/cgi-bin/prn...rategicHealthcareServicesforInfoLogix,Mr.Waywillbe...
(Date:11/23/2009)...rsenic compounds appears to cause oxidative DNA da...ing to a new study published online November 23 in..., Although biomethylation was once believed to de...ance its toxicity and potentially its carcinogenic...ation in oxidative DNA damage in mice, Michael P. ...
(Date:11/23/2009)...lth care professionals enjoy a pay raise for a job...tives for health care performance may actually bac...care performance ratings for 25 medical groups acr...e launch of a statewide pay-for-performance progra...ors, productivity. , Reporting in the Decembe...
(Date:11/23/2009)...ers getting chemo deal with insomnia, study shows ...Insomnia and sleep disorders affect more than thre...apy, a rate nearly three times higher than that of...he problem is more common in younger patients and ...sity of Rochester Medical Center researchers, who ...
(Date:11/23/2009)...esses of drug approval process in United States, r...thDay News) -- Problems with the popular arthritis...tack, stroke and death, were known for years befor...in 2004, a new report says. , Contrary to clai... side effects were evident in 2000, a year after t...
Breaking Medicine News(10 mins):Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
(Date:11/23/2009)...N,Nov.23/PRNewswire-USNewswire/--FebeDurango-Rueda...toparticipatinginaschemetodefraudtheExport-ImportB...,announcedAssistantAttorneyGeneraloftheCriminalDiv...L.GratacosoftheEx-ImBank,OfficeoftheInspectorGener...RobertsinU.S.DistrictCourtinWashingtontoaone-count...
(Date:11/23/2009)...Ga.,Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nas...ument-reagentsystemstothebloodtransfusionindustry,...rJaffray21stAnnualHealthCareConferenceinNewYork,NY... TheCompany,spresentationisscheduledforTuesday,Dec...entationwillbeavailablethroughthe"AboutUs--Investo...
(Date:11/23/2009)...AKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(Nas...gforBestOverallPipelineandforBestNewDrugforNplate&..., TheBestOverallPipelineawardwaspresentedtoAmgenby...etpotentialofthecompany,spipeline,aswellasitsmixof...dges,Amgen,spipelineisnotableforitsfocusonunmetcli...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 1Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 2Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 1Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 2Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 3Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 4Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 5Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 6Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 1Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 2Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 3
Other News:
...tes, the total fertility rate the number of child...r eight in 1800 to slightly more than two today, s...y at Binghamton University. And with a five-year $... Health and Human Development, Hacker hopes to fin...
...aturdays Congressional action to avert Medicare pa...he future of internal medicine, the American Colle...f appreciation to lawmakers.... ACP told members o...re physician payment "will avert a 5 percent payme...
DALLAS Dec. 13, 2006 Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the b
...n struggles to read because even small...distracti.....dyslexia emerging from a group of recent studies...r-old theory that...blamed dyslexia on a neural de...... Instead, the studies suggest that children wit...
health news:Binghamton University researcher to study declining US fertility rates 2health news:Congressional action strengthens internal medicine ACP says 2health news:Congressional action strengthens internal medicine ACP says 3health news:Drug that chokes off tumor blood vessels offers new hope to lung cancer patients 2health news:New dyslexia theory blames 'noise' 2health news:New dyslexia theory blames 'noise' 3health news:New dyslexia theory blames 'noise' 4
...ity of California San Francisco and.Kaiser Permane...rapy reduces the.risk of spinal fractures in women...dings are important because women with osteoporosi...lternative for treatment," said Bruce Ettinger,.MD...
...m across the country will join with.UCSF faculty f...enges in.Integrative Medicine: Toward a New Scienc...nt of the new Osher Center for Integrative Medicin... Afternoon Symposium:.Date: Friday, September 25, ...
...ve tooth damage)...Elizabeth O'Sullivan and Martin...y at Leeds Dental Institute suggest that some drug...n in children. In their letter published in this ...children using asthma drugs in a powdered (rather ...
.Last year, a minor earthquake erupted inside Johnnie Beavers' chest. . But yesterday, in a Kentucky medical first, physicians at the University of Kentucky Hospital used an experimental new technique
health news:Novel Therapy Significantly Reduces Spinal Fractures In Postmenopausal WomenWith Two Years Of Therapy 2health news:Novel Therapy Significantly Reduces Spinal Fractures In Postmenopausal WomenWith Two Years Of Therapy 3health news:UCSF Osher Center For Integrative Medicine Symposium 2health news:University Of Kentucky One Of First To Use New Technique To Treat Atrial Flutter 2health news:University Of Kentucky One Of First To Use New Technique To Treat Atrial Flutter 3